Mason Carrico

Stock Analyst at Stephens & Co.

(0)
# 4335
Out of 5,271 analysts
68
Total ratings
25.93%
Success rate
-11.06%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
Establishment Labs H...
Reiterates: Overweight
52 52
42.96 21.04% 1 Feb 27, 2025
CareDx
Reiterates: Overweight
40 40
21.14 89.21% 9 Feb 27, 2025
Pacific Biosciences
Reiterates: Overweight
3 3
1.31 90.84% 4 Feb 18, 2025
Staar Surgical
Reiterates: Equal-Weight
28 28
16.38 70.94% 1 Feb 12, 2025
Hologic
Reiterates: Overweight
84 84
63.23 32.85% 3 Feb 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
14 13
13.02 -0.15% 1 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
20 20
10.36 93.05% 4 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
65 65
49.34 31.74% 1 Jan 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
41 41
21.34 92.13% 7 Jan 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
170 184
84.2 118.53% 6 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
30 30
9.85 204.57% 5 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
125 125
143.16 -12.69% 4 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
19 19
9.6 97.92% 1 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
44 44
40.76 7.95% 4 May 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
2 2
n/a n/a 4 Apr 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
4
2.77 44.4% 3 Apr 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
4.3 109.3% 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 9
1.55 480.65% 4 Nov 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
34
33.59 1.22% 5 Oct 10, 2023